Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01277159 · ClinicalTrials.gov registry record · NA

Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine

A NA study, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
108
Enrollment target

NCT01277159 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 108 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01277159, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

Patients scheduled to go home after ankle surgery at HSS typically receive a sciatic nerve block in the popliteal fossa and oral analgesic tablets (such as Percocet). Popliteal fossa nerve blockade has reduced pain for these patients (YaDeau et al, Anesth Analg 2008;106:1916-20), but unfortunately the patients still often experience moderate to severe pain after the block wears off. The investigators wish to study two additives that may prolong the period of analgesia provided by the nerve block. The additives will be studied in the context of a standardized postoperative multimodal analgesic pathway. Primary outcome: Does adding dexamethasone and / or buprenorphine prolong the analgesia provided by a popliteal fossa nerve block?

Interventions

  • DRUG A. Control Nerve Block. IV Dexamethasone (4 mg).
  • DRUG B. Nerve Block with Dexamethasone (4 mg). IV saline.
  • DRUG C. Control Nerve Block. IV Dexamethasone (4 mg). IV Buprenorphine (0.3 mg)
  • DRUG D. Nerve Block with Buprenorphine (0.3 mg). IV Dexamethasone (4 mg).
  • DRUG E. Nerve Block with Dexamethasone (4 mg) / block Buprenorphine (0.3 mg).

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2010-10
Est. Completion 2011-12
Phase NA

What the Registry Record Tells You About NCT01277159

The ClinicalTrials.gov registry entry for NCT01277159 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which A. Control Nerve Block. IV Dexamethasone (4 mg). is the first listed.

NCT01277159 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01277159 about?

NCT01277159 is a clinical study titled "Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine". Patients scheduled to go home after ankle surgery at HSS typically receive a sciatic nerve block in the popliteal fossa and oral analgesic tablets (such as Percocet). Popliteal fossa nerve blockade has reduced pain for these patients (YaDeau et al, Anesth Analg 2008;106:1916-20), but unfortunately t...

What is the current status of trial NCT01277159?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2010-10. Estimated completion is 2011-12.

What interventions are being tested in trial NCT01277159?

The interventions under investigation include: A. Control Nerve Block. IV Dexamethasone (4 mg). (DRUG), B. Nerve Block with Dexamethasone (4 mg). IV saline. (DRUG), C. Control Nerve Block. IV Dexamethasone (4 mg). IV Buprenorphine (0.3 mg) (DRUG), D. Nerve Block with Buprenorphine (0.3 mg). IV Dexamethasone (4 mg). (DRUG), E. Nerve Block with Dexamethasone (4 mg) / block Buprenorphine (0.3 mg). (DRUG).

Who is sponsoring clinical trial NCT01277159?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.